Argitalpenak (101) ROBERTO ALFONSO ALONSO FERNÁNDEZ argitalpenak

2024

  1. A solution to achieve sequencing from SARS-CoV-2 specimens with low viral loads: concatenation of reads from independent reactions

    Virology journal, Vol. 21, Núm. 1, pp. 121

  2. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  3. Candida spp.: the burden of a microorganism in a microbiology department

    Microbiology Spectrum, Vol. 12, Núm. 8

  4. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection, Vol. 52, Núm. 3, pp. 813-824

  5. Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4+ T-Cell Lymphopenia but Preserved Responses to CMV

    Vaccines, Vol. 12, Núm. 4

  6. Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

    Frontiers in Immunology, Vol. 15

  7. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

    Journal of Medical Virology

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Acute Epstein–Barr virus infection: Diagnostic challenge in young children, risk factors for hospitalisation and cytomegalovirus co-detection

    Acta Paediatrica, International Journal of Paediatrics, Vol. 112, Núm. 6, pp. 1287-1295

  3. Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert

    Microbiology Spectrum, Vol. 11, Núm. 5

  4. Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later

    Birth, Vol. 50, Núm. 2, pp. 418-427

  5. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 194-200

  6. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain

    Emerging infectious diseases, Vol. 29, Núm. 6, pp. 1154-1161

  7. Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

    Antimicrobial agents and chemotherapy, Vol. 67, Núm. 7, pp. e0026623

  8. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients

    Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 3, pp. 526-536

  9. Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

    Journal of Fungi, Vol. 9, Núm. 4

  10. Rapid Identification of Relevant Microbial Strains by Identifying Multiple Marker Single Nucleotide Polymorphisms via Amplicon Sequencing: Epidemic Monkeypox Virus as a Proof of Concept

    Microbiology Spectrum, Vol. 11, Núm. 1

  11. Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID

    BMC Pregnancy and Childbirth, Vol. 23, Núm. 1

  12. Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

    Genome medicine, Vol. 15, Núm. 1, pp. 57

2022

  1. Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines

    Biomedicines, Vol. 10, Núm. 7